InMode (INMD) Net Cash Flow Growth (3y) (2021 - 2026)
Powered by 
Analysis
InMode (INMD) Net Cash Flow Growth (3y) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | -9.45% |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | -16.59% |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | -0.80% |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | 60.16% |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | -85.83% |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | 43.26% |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | 1.60% |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | -26.30% |
| 9 | Steris | 21.90 Bn | 21.43 Bn | 684.20 Mn | 269.22% |
| 10 | InMode | 944.68 Mn | 462.56 Mn | 71.52 Mn | -67.74% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -67.74% |
| Mar 31, 2026 | 177.20% |
| Dec 31, 2025 | 36.87% |
| Sep 30, 2025 | 78.02% |
| Jun 30, 2025 | 15.33% |
| Mar 31, 2025 | 24.74% |
| Dec 31, 2024 | -115.36% |
| Sep 30, 2024 | 112.34% |
| Jun 30, 2024 | -109.26% |
| Mar 31, 2024 | -82.13% |
| Dec 31, 2023 | 181.87% |
| Sep 30, 2023 | -105.59% |
| Jun 30, 2023 | 50.82% |
| Mar 31, 2023 | -111.10% |
| Dec 31, 2022 | 88.94% |
| Sep 30, 2022 | -35.75% |
| Jun 30, 2022 | 65.31% |
| Mar 31, 2022 | -59.00% |
| Dec 31, 2021 | -29.99% |
| Sep 30, 2021 | 37.68% |